Literature DB >> 16715461

[Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)].

Karl-Heinz Janke1, Bodo Klump, Ulf Steder-Neukamm, Jörg Hoffmann, Winfried Häuser.   

Abstract

The Inflammatory Bowel Disease Questionnaire (IBDQ) is the standard disease-specific instrument for assessment of health-related quality of life (HRQOL) in patients with inflammatory bowel diseases (IBD). A German translation has not been validated. 415 outpatient IBD-patients (Crohn's Disease n = 306, Ulcerative Colitis n = 109) completed the German version of the IBDQ (Competence network IBD, IBDQ-D), the Hospital Anxiety and Depression Scale German Version (HADS-D) and the Questions on Life Satisfaction FLZ. Face validity was assessed by a physicians' and patients' panel. Disease activity was measured by the German Inflammatory Bowel Disease Activity Index (GIBDI). With 97.3 % completed items the acceptance was high. The Cronbach's alpha for the subscales ranged from 0.88 to 0.89. The correlation coefficients with comparable subscales of other instruments ranged between 0.09 and 0.70. Patients in remission and different disease activities differed significantly (p < 0.001) in all IBDQ-D-subscales.

Entities:  

Mesh:

Year:  2006        PMID: 16715461     DOI: 10.1055/s-2006-932661

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  7 in total

Review 1.  Assessing patient reported outcome measures: A practical guide for gastroenterologists.

Authors:  Laith Alrubaiy; Hayley A Hutchings; John G Williams
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

2.  The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.

Authors:  Stefan Begré; Benjamin Misselwitz; Sebastian Bruno Ulrich Jordi; Brian Matthew Lang; Jacqueline Wyss; Bianca Auschra; Bahtiyar Yilmaz; Niklas Krupka; Thomas Greuter; Philipp Schreiner; Luc Biedermann; Martin Preisig; Roland von Känel; Gerhard Rogler
Journal:  J Gastroenterol       Date:  2022-07-28       Impact factor: 6.772

3.  The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.

Authors:  Máté Krausz; Annette Uhlmann; Ina Caroline Rump; Gabriele Ihorst; Sigune Goldacker; Georgios Sogkas; Sara Posadas-Cantera; Reinhold Schmidt; Manuel Feißt; Laia Alsina; Ingunn Dybedal; Mike Recher; Klaus Warnatz; Bodo Grimbacher
Journal:  Contemp Clin Trials Commun       Date:  2022-09-24

4.  Sexual function and quality of life after surgical treatment for anal fistulas in Crohn's disease.

Authors:  S Riss; K Schwameis; M Mittlböck; M Pones; H Vogelsang; W Reinisch; M Riedl; A Stift
Journal:  Tech Coloproctol       Date:  2012-09-06       Impact factor: 3.781

5.  Beneficial Effects of Education on Emotional Distress, Self-Management, and Coping in Patients with Inflammatory Bowel Disease: A Prospective Randomized Controlled Study.

Authors:  Anja Berding; Christine Witte; Marion Gottschald; Birgit Kaltz; Romy Weiland; Christian Gerlich; Andrea Reusch; Wolfgang Kruis; Hermann Faller
Journal:  Inflamm Intest Dis       Date:  2016-11-30

6.  Perianal fistulodesis - A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae.

Authors:  Roxanne Villiger; Daniela Cabalzar-Wondberg; Daniela Zeller; Pascal Frei; Luc Biedermann; Christian Schneider; Michael Scharl; Gerhard Rogler; Matthias Turina; Andreas Rickenbacher; Benjamin Misselwitz
Journal:  World J Gastrointest Surg       Date:  2021-02-27

7.  Mind-body-medicine and comprehensive lifestyle-modification in patients with Crohn's disease-Feasibility of a randomized controlled trial under pandemic circumstances.

Authors:  Nina Bauer; Claudia Löffler; Özlem Öznur; Christine Uecker; Thomas Keil; Jost Langhorst
Journal:  Front Integr Neurosci       Date:  2022-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.